Friday, U.S. stock index futures opened low on Wall Street. S&P 500 futures dipped 0.2%. Dow Jones was 0.2% down while it was 0.04% up for Nasdaq.
Intel Corp. reported higher revenue for the 4th quarter and sees a better 2011 start opposing concerns on its small role in the thriving market of smartphones and tablets. Its Frankfurt shares went 2.8% up while semiconductor companies’ shares rallied in Japan and Europe.
JP Morgan results were anticipated by investors to start earning time for the banking industry. It is seen to post lesser trading revenues out of investment banking compared to an earlier year. Debt and equity underwriting revenue improved.
On the macro front, the market has a lot of data to absorb such as the consumer price index, retails sales in December and the Reuters/University of Michigan sentiment.
Oil and metal did a slide as Alaska’s main oil pipeline neared complete shipments volume. Central bank in China, a top metal consumer, increased reserves required to lenders by 50 basis points to combat fast inflation in the country.
Sanofi-Aventis expects to capture a deal that give U.S. target Genzyme a $76/share value ($20 billion) said the daily Le Figaro on Friday.
Merck’s Thursday slide affected U.S. stocks and went lower while declining commodities prices hit shares of natural resource companies. Dow Jones industrial average dived to 11,731.90 (23.54 points or 0.20%). The S&P 500 index was down 0.17% to 1,283.76 (2.20 points). The Nasdaq Composite index was down too to 2,735.29 (2.04 points or 0.07%).